SCHEDULE 13G FOR ACLARIS THERAPEUTICS, INC. BY MFN PARTNERS, LP

Company

Aclaris Therapeutics, Inc.

Filed

October 31, 2019

Accession Number

0000904454-19-000691

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →